Vitamin D and chronic diseases

Aging and Disease

Volumn 8, Issue 3, 2017, Pages 346-353

  Wang, Hanmin ^a   Chen, Weiwen ^a   Li, Dongqing ^a   Yin, Xiaoe ^a   Zhang, Xiaode ^a   Olsen, Nancy ^b   Zheng, Song Guo ^a,b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Chronic diseases; Deficiency; Early prevention; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERLEUKIN 2; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; VITAMIN D; VITAMIN D BINDING PROTEIN;

AGING; ALZHEIMER DISEASE; ARTERIAL STIFFNESS; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DISEASE; COGNITIVE DEFECT; COLORECTAL CANCER; ENDOTHELIAL DYSFUNCTION; EPILEPSY; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; IMMUNE RESPONSE; INFECTION CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOMALACIA; OSTEOPOROSIS; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN EXPRESSION; QUALITY OF LIFE; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

EID: 85021130539     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2016.1021     Document Type: Article

References (104)

1. Holick MF (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr, 80: 1678s-1688s
2. Mathieu C, Badenhoop K (2005). Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab, 16: 261-266
3. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M (2008). Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics, 122: 398-417
4. Handono K, Sidarta YO, Pradana BA, Nugroho RA, Hartono IA, Kalim H, et al. (2014). Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus. Acta Med Indones, 46: 189-198
5. (2015). Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis. PLoS One, 10: e0131260
6. Van Belle TL, Vanherwegen AS, Feyaerts D, De Clercq P, Verstuyf A, Korf H, et al. (2014). 1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients. PLoS One, 9: e109194
7. Reddy KK (2013). Reply to Glossmann: vitamin D compounds and oral supplementation methods. J Invest Dermatol, 133: 2649
8. Takahashi H, Hatta Y, Iriyama N, Hasegawa Y, Uchida H, Nakagawa M, et al. (2014). Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1alpha,25-dihydroxyvitamin D3. PLoS One, 9: e113722
9. Zhang Z, Zhang H, Hu Z, Wang P, Wan J, Li B (2014). Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells. Oncol Lett, 8: 1348-1354
10. Henry HL (2011). Regulation of vitamin D metabolism.Best Pract Res Clin Endocrinol Metab, 25: 531-541
11. Hossein-nezhad A, Holick MF (2013). Vitamin D for health: a global perspective. Mayo Clin Proc, 88: 720-755
12. Cantorna MT, Zhu Y, Froicu M, Wittke A (2004). Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr, 80: 1717s-1720s
13. Ahmed SZ, Jaleel A, Hameed K, Qazi S, Suleman A (2015). DOES VITAMIN D DEFICIENCY CONTRIBUTE TO THE SEVERITY OF ASTHMA IN CHILDREN AND ADULTS? J Ayub Med Coll Abbottabad, 27: 458-463
14. Holick MF (2007). Vitamin D deficiency. N Engl J Med, 357: 266-281
15. Hossein-nezhad A, Holick MF (2012). Optimize dietary intake of vitamin D: an epigenetic perspective. Curr Opin Clin Nutr Metab Care, 15: 567-579
16. Holick MF (2012). Vitamin D: extraskeletal health. Rheum Dis Clin North Am, 38: 141-160
17. Kim SH, Choi GS, Nam YH, Kim JH, Hur GY, Kim SH, et al. (2012). Role of vitamin D-binding protein in isocyanate-induced occupational asthma. Exp Mol Med, 44: 319-329
18. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, et al. (1999). Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest, 103: 239-251
19. Taes YE, Goemaere S, Huang G, Van Pottelbergh I, De Bacquer D, Verhasselt B, et al. (2006). Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone, 38: 701-707
20. Weinstein SJ, Purdue MP, Smith-Warner SA, Mondul AM, Black A, Ahn J, et al. (2015). Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer, 136: E654-664
21. Hou JC, Min L, Pessin JE (2009). Insulin granule biogenesis, trafficking and exocytosis.Vitam Horm, 80: 473-506
22. Johnson JA, Grande JP, Roche PC, Kumar R (1994). Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol, 267: E356-360
23. Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C (2005). The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol, 349: 248-260
24. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005). Estimates of optimal vitamin D status. Osteoporos Int, 16: 713-716
25. Chen W, Zhang X, Wang H, Zhang W, Xu Y, Zheng S (2015). The epidemic investigation of serum 25-hydroxy vitamin D levels in the adults in Qujing area of Yunnan province in China. Int J Clin Exp Pathol, 8: 9597-9601
26. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT (2011). Vitamin D status: United States, 2001-2006. NCHS Data Brief: 1-8
27. Ginde AA, Liu MC, Camargo CA, Jr. (2009). Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med, 169: 626-632
28. Genuis SJ, Schwalfenberg GK, Hiltz MN, Vaselenak SA (2009). Vitamin D status of clinical practice populations at higher latitudes: analysis and applications. Int J Environ Res Public Health, 6: 151-173
29. Oliveri B, Plantalech L, Bagur A, Wittich AC, Rovai G, Pusiol E, et al. (2004). High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. Eur J Clin Nutr, 58: 337-342
30. Burnand B, Sloutskis D, Gianoli F, Cornuz J, Rickenbach M, Paccaud F, et al. (1992). Serum 25-hydroxyvitamin D: distribution and determinants in the Swiss population. Am J Clin Nutr, 56: 537-542
31. Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, et al. (2003). Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc, 51: 1533-1538
32. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. (2004). Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health, 4: 38
33. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, Sawhney RC, et al. (2005). Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr, 82: 477-482
34. Daniels ED, Pettifor JM, Schnitzler CM, Moodley GP, Zachen D (1997). Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women. Osteoporos Int, 7: 105-112
35. Zhang Q, Xiao-Qi HU, Guo HX (2010). VITAMIN D NUTRITION STATUS IN CHINESE TIBETAN AND HAN NATIONALITY CHILDREN AND ADOLESCENTS. Modern Preventive Medicine, 37:465-467
36. Unger MD, Cuppari L, Titan SM, Magalhaes MC, Sassaki AL, dos Reis LM, et al. (2010). Vitamin D status in a sunny country: where has the sun gone? Clin Nutr, 29: 784-788
37. Hammad LN, Abdelraouf SM, Hassanein FS, Mohamed WA, Schaalan MF (2013). Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? J Immunotoxicol, 10: 380-386
38. Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, Albanes D (2013). Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer, 132: 2940-2947
39. Mondul AM, Weinstein SJ, Virtamo J, Albanes D (2012). Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer, 107: 1589-1594
40. Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, Jiang W, et al. (2010). Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One, 5: e13428
41. Gressner OA, Gao C, Siluschek M, Kim P, Gressner AM (2009). Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 21: 990-995
42. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. (2005). Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol, 97: 179-194
43. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst, 98: 451-459
44. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000). Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control, 11: 847-852
45. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. (2004). Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev, 13:1502-1508
46. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. (2006). The role of vitamin D in cancer prevention. Am J Public Health, 96: 252-261
47. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007). Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr, 85: 1586-1591
48. Lavie CJ, Dinicolantonio JJ, Milani RV, O'Keefe JH (2013). Vitamin D and cardiovascular health. Circulation, 128: 2404-2406
49. Ferder M, Inserra F, Manucha W, Ferder L (2013). The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol Cell Physiol, 304: C1027-1039
50. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, et al. (2005). 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation, 111: 1666-1671
51. Fernandes dA, D. A. (2009). Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology, 34 Suppl 1: S265-S277
52. Stumpf WE (2012). Drugs in the brain-cellular imaging with receptor microscopic autoradiography. Prog Histochem Cytochem, 47: 1-26
53. Norman PE, Powell JT (2014). Vitamin D and cardiovascular disease. Circ Res, 114: 379-393
54. Borges AC, Feres T, Vianna LM, Paiva TB (1999). Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension, 34: 897-901
55. Uberti F, Lattuada D, Morsanuto V, Nava U, Bolis G, Vacca G, et al. (2014). Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab, 99: 1367-1374
56. Polidoro L, Properzi G, Marampon F, Gravina GL, Festuccia C, Di Cesare E, et al. (2013). Vitamin D protects human endothelial cells from H(2)O(2) oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res, 6: 221-231
57. Carvalho LS, Sposito AC (2015). Vitamin D for the prevention of cardiovascular disease: Are we ready for that? Atherosclerosis, 241: 729-740
58. Talmor Y, Bernheim J, Klein O, Green J, Rashid G (2008). Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest, 38: 548-554
59. Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R (2000). 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation, 102: 2867-2872
60. Brewer LC, Michos ED, Reis JP (2011). Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets, 12: 54-60
61. Pilz S, Gaksch M, O'Hartaigh B, Tomaschitz A, Marz W (2013). The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013? Arch Toxicol, 87: 2083-2103
62. Oh J, Riek AE, Darwech I, Funai K, Shao J, Chin K, et al. (2015). Deletion of macrophage Vitamin D receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice. Cell Rep, 10: 1872-1886
63. Harinarayan CV (2014). Vitamin D and diabetes mellitus. Hormones (Athens), 13: 163-181
64. Lim S, Kim MJ, Choi SH, Shin CS, Park KS, Jang HC, et al. (2013). Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr, 97: 524-530
65. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. (2013). Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med, 10: e1001383
66. Al-Timimi DJ, Ali AF (2013). Serum 25(OH) D in Diabetes Mellitus Type 2: Relation to Glycaemic Control. J Clin Diaqn Res, 7: 2686-2688
67. Baeke F, Gysemans C, Korf H, Mathieu C (2010). Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol, 25: 1597-1606
68. Cheng Q, Li YC, Boucher BJ, Leung PS (2011). A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia, 54: 2077-2081
69. Kadowaki S, Norman AW (1984). Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest, 73: 759-766
70. Redecker P, Cetin Y (1997). Rodent pancreatic islet cells contain the calcium-binding proteins calcineurin and calretinin. Histochem Cell Biol, 108: 133-139
71. Bourlon PM, Faure-Dussert A, Billaudel B, Sutter BC, Tramu G, Thomasset M (1996). Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1,25-dihydroxyvitamin D3. J Endocrinol, 148: 223-232
72. Jeffery LE, Qureshi OS, Gardner D, Hou TZ, Briggs Z, Soskic B, et al. (2015). Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function. PLoS One, 10: e0131539
73. Moreira TS, Hamadeh MJ (2010). The role of vitamin D deficiency in the pathogenesis of type 2 diabetes mellitus. E-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 5: e155-e165
74. Rigby WF, Denome S, Fanger MW (1987). Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest, 79: 1659-1664
75. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, et al. (2007). IFN-gamma-and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol, 178: 7190-7198
76. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A (2009). 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine, 45: 190-197
77. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007). Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol, 179: 1634-1647
78. Harms LR, Burne TH, Eyles DW, McGrath JJ (2011). Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab, 25: 657-669
79. Kesby JP, Eyles DW, Burne TH, McGrath JJ (2011). The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol, 347: 121-127
80. Bertone-Johnson ER, Powers SI, Spangler L, Brunner RL, Michael YL, Larson JC, et al. (2011). Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr, 94: 1104-1112
81. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW (2008). Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry, 65: 508-512
82. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K (2008). Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Inetrn Med, 264: 599-609
83. Annweiler C, Llewellyn DJ, Beauchet O (2013). Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis, 33: 659-674
84. Hollo A, Clemens Z, Kamondi A, Lakatos P, Szucs A (2012). Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav, 24: 131-133
85. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC (2006). Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry, 14: 1032-1040
86. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, et al. (2010). Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med, 170: 1135-1141
87. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005). Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat, 29: 21-30
88. Jande SS, Maler L, Lawson DE (1981). Immunohistochemical mapping of vitamin D-dependent calcium-binding protein in brain. Nature, 294: 765-767
89. Partonen T (1998). Vitamin D and serotonin in winter. Med Hypotheses, 51: 267-268
90. Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, et al. (2009). 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis, 17: 703-717
91. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, et al. (2010). 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology, 74: 18-26
92. Perez-Lopez FR (2007). Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas, 58: 117-137
93. Looker AC, Mussolino ME (2008). Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res, 23: 143-150
94. Adams JS, Hewison M (2008). Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab, 4: 80-90
95. Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, et al. (2011). Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut, 60: 1728-1737
96. Neeman R, Abramovitch S, Sharvit E, Elad-Sfadia G, Haklai R, Kloog Y, et al. (2014). Vitamin D and S-farnesylthiosalicylic acid have a synergistic effect on hepatic stellate cells proliferation. Dig Dis Sci, 59: 2462-2469
97. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. (2010). Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology, 51: 1158-1167
98. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, et al. (2011). Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol, 54: 887-893
99. Choudhary NS, Tomar M, Chawla YK, Bhadada SK, Khandelwal N, Dhiman RK, et al. (2011). Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig Dis Sci, 56: 3323-3327
100. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. (2007). Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis, 17: 517-524
101. Embry AF, Snowdon LR, Vieth R (2000). Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol, 48: 271-272
102. Guenther L, Van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, et al. (2002). Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol, 147: 316-323
103. Sanghi D, Mishra A, Sharma AC, Singh A, Natu SM, Agarwal S, et al. (2013). Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res, 471: 3556-3562
104. Nakagawa Y, Koizumi M, Fukagawa M (2015). Current Topics on Vitamin D. Vitamin D and chronic kidney disease. Clin Calcium, 25: 413-423